Oculocerebrocutaneous syndrome

Oculocerebrocutaneous syndrome (OCCS), also known as Delleman syndrome or Delleman-Oorthuys syndrome, is an extremely rare congenital disorder characterized by a triad of abnormalities affecting the eyes (ocular), brain (cerebral), and skin (cutaneous). The condition is typically apparent at birth and involves a combination of distinctive malformations across multiple organ systems. The ocular features are among the most prominent and may include orbital cysts, microphthalmia (abnormally small eyes) or anophthalmia (absence of one or both eyes), and eyelid colobomas. Neurological abnormalities frequently include cerebral malformations such as agenesis of the corpus callosum, intracranial cysts (particularly arachnoid or porencephalic cysts), and significant intellectual disability. Cutaneous findings include focal areas of skin aplasia or hypoplasia, skin appendages (skin tags), and periorbital or other facial skin defects. Additional features may include seizures, facial asymmetry, and occasionally skeletal or cardiovascular anomalies. The exact cause of oculocerebrocutaneous syndrome remains unclear, though it is generally considered to occur sporadically, with most cases arising as isolated events without a family history. No specific gene has been definitively identified as causative. There is no cure for OCCS, and management is supportive and symptomatic, often requiring a multidisciplinary team including ophthalmologists, neurologists, dermatologists, and developmental specialists. Surgical interventions may be needed for orbital cysts, skin abnormalities, or other structural defects. Early intervention programs and therapies are important for addressing developmental delays.

Common questions about Oculocerebrocutaneous syndrome